Journey Advisory Group »

Immunitybio shares owned by Journey Advisory Group

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Journey Advisory Group from 13F filings

Historical chart of Journey Advisory Group investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Journey Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Journey Advisory Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $109k 14k 7.67

More positions owned by Journey Advisory Group

Ishares Tr 0-3 Mnth Treasry (SGOV)
Pimco Etf Tr Multisector Bd (PYLD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Latn Amer 40 Etf (ILF)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Doubleline Etf Trust Opportunistic Co (DBND)
JPMorgan Chase & Co. (JPM)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ssga Active Etf Tr State Street Dou (TOTL)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Eli Lilly & Co. (LLY)

View all positions for Journey Advisory Group

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio